External Validation of Five Scores to Predict Stroke-Associated Pneumonia and the Role of Selected Blood Biomarkers

Author:

Hotter Benjamin1ORCID,Hoffmann Sarah1,Ulm Lena12ORCID,Meisel Christian3ORCID,Bustamante Alejandro4,Montaner Joan5,Katan Mira6,Smith Craig J.7,Meisel Andreas1

Affiliation:

1. Charité—Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Center for Stroke Research Berlin, NeuroCure Clinical Research Center and Department of Neurology, Charité University Hospital Berlin, Germany (B.H., S.H., L.U., A.M.).

2. Friedrich Loeffler Institute of Medical Microbiology, University Medicine Greifswald, Germany (L.U.).

3. Department of Medical Immunology, Charité University Medicine & Labor Berlin—Charité Vivantes, Germany (C.M.).

4. Neurovascular Research Laboratory, Vall d’Hebron Institut de Recerca, Spain (A.B.).

5. Stroke Research Program, Institute of Biomedicine of Seville, IBiS/Hospital Universitario Virgen del Rocio/CSIC/University of Seville & Department of Neurology, Hospital Universitario Virgen Macarenca, Spain (J.M.).

6. Department of Neurology, UniversitätsSpital Zürich, Switzerland (M.K.).

7. Division of Cardiovascular Sciences, University of Manchester, Lydia Becker Institute of Immunology and Inflammation, Manchester Centre for Clinical Neurosciences, Salford, United Kingdom (C.J.S.).

Abstract

Background and Purpose: Several clinical scoring systems as well as biomarkers have been proposed to predict stroke-associated pneumonia (SAP). We aimed to externally and competitively validate SAP scores and hypothesized that 5 selected biomarkers would improve performance of these scores. Methods: We pooled the clinical data of 2 acute stroke studies with identical data assessment: STRAWINSKI and PREDICT. Biomarkers (ultrasensitive procalcitonin; mid-regional proadrenomedullin; mid-regional proatrionatriuretic peptide; ultrasensitive copeptin; C-terminal proendothelin) were measured from hospital admission serum samples. A literature search was performed to identify SAP prediction scores. We then calculated multivariate regression models with the individual scores and the biomarkers. Areas under receiver operating characteristic curves were used to compare discrimination of these scores and models. Results: The combined cohort consisted of 683 cases, of which 573 had available backup samples to perform the biomarker analysis. Literature search identified 9 SAP prediction scores. Our data set enabled us to calculate 5 of these scores. The scores had area under receiver operating characteristic curve of 0.543 to 0.651 for physician determined SAP, 0.574 to 0.685 for probable and 0.689 to 0.811 for definite SAP according to Pneumonia in Stroke Consensus group criteria. Multivariate models of the scores with biomarkers improved virtually all predictions, but mostly in the range of an area under receiver operating characteristic curve delta of 0.05. Conclusions: All SAP prediction scores identified patients who would develop SAP with fair to strong capabilities, with better discrimination when stricter criteria for SAP diagnosis were applied. The selected biomarkers provided only limited added predictive value, currently not warranting addition of these markers to prediction models. Registration: URL: https://www.clinicaltrials.gov . Unique identifier: NCT01264549 and NCT01079728.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Advanced and Specialised Nursing,Cardiology and Cardiovascular Medicine,Clinical Neurology

Reference15 articles.

1. Medical complications after stroke

2. Preventive antibiotic therapy in stroke: PASSed away?;Meisel A;Lancet,2015

3. Central nervous system injury-induced immune deficiency syndrome

4. Clinical risk scores for predicting stroke-associated pneumonia: a systematic review.;Kishore AK;Eur Stroke J,2016

5. Inflammatory and stress markers predicting pneumonia, outcome and etiology in stroke patients.;Hotter B;Neurol,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3